DTPA is contraindicated in individuals with known hypersensitivity to the compound. Caution is advised in patients with renal impairment, as the excretion of the DTPA-metal complex primarily occurs through the kidneys. In such cases, the risk of accumulation and toxicity may increase. Pregnant or breastfeeding women should only use DTPA if the potential benefits outweigh the risks.
